STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 72 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -98.9% | 379 | -98.8% | 0.00% | – |
| Q1 2021 | $90,000 | +13.9% | 32,600 | 0.0% | 0.00% | – |
| Q4 2020 | $79,000 | +16.2% | 32,600 | 0.0% | 0.00% | – |
| Q3 2020 | $68,000 | -44.7% | 32,600 | 0.0% | 0.00% | – |
| Q2 2020 | $123,000 | +2360.0% | 32,600 | +1107.4% | 0.00% | – |
| Q1 2020 | $5,000 | -93.5% | 2,700 | -92.7% | 0.00% | – |
| Q4 2019 | $77,000 | -12.5% | 36,800 | 0.0% | 0.00% | – |
| Q3 2019 | $88,000 | -23.5% | 36,800 | 0.0% | 0.00% | – |
| Q2 2019 | $115,000 | -49.8% | 36,800 | +42.1% | 0.00% | – |
| Q1 2018 | $229,000 | +175.9% | 25,900 | +125.2% | 0.00% | – |
| Q4 2017 | $83,000 | +5.1% | 11,500 | 0.0% | 0.00% | – |
| Q3 2017 | $79,000 | +29.5% | 11,500 | +35.3% | 0.00% | – |
| Q2 2017 | $61,000 | – | 8,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,376,039 | $47,309,000 | 51.34% |
| Lyon Street Capital, LLC | 3,182,149 | $28,162,000 | 9.07% |
| Opaleye Management Inc. | 1,590,000 | $14,071,000 | 4.02% |
| Broadfin Capital, LLC | 2,793,752 | $24,725,000 | 3.85% |
| Vivo Capital, LLC | 1,918,132 | $16,975,000 | 2.40% |
| ARMISTICE CAPITAL, LLC | 3,372,000 | $29,842,000 | 2.28% |
| PRECEPT MANAGEMENT LLC | 470,000 | $4,160,000 | 1.73% |
| NEA Management Company, LLC | 4,141,308 | $36,651,000 | 1.63% |
| Harvest Capital Strategies LLC | 825,000 | $7,301,000 | 1.14% |
| Granite Point Capital Management, L.P. | 567,895 | $5,026,000 | 0.49% |